May 13, 2016
Asthma, asthma study, bronchodilators, combination inhalers, corticosteroids, FDA, inhaler, medicine, The Asthma Center

Good news for anyone with persistent asthma!

The Asthma Center physicians were investigators in a breakthrough clinical trial which serves as the basis for a new asthma study just released  yesterday in the New England Journal of Medicine (NEJM) which confirmed the safety of combination inhaled corticosteroids with long acting bronchodilators in patients with persistent asthma. 

The results apply to products like Breo, Advair, Dulera and Symbicort.  These longstanding inhaler products are commonly prescribed to help asthma sufferers get relief and keep asthma under control.  For several years, these medications have been under the watchful eye of the Food & Drug Administration (FDA) amid concerns regarding risk of asthma related deaths and/or asthma exacerbations associated with the use of these combination inhalers.

This new 26 week study showed that salmeterol (Serevent) in combination with fluticasone (Flovent) [Comparable to Advair] did not have a significantly higher risk of serious asthma related events, including death, than those treated with Fluticasone alone.

In fact, subjects on combined salmeterol and Fluticasone had fewer asthma flares compared to those treated with Fluticasone alone.

In summary, The Asthma Center specialists continue to be confident in the efficacy and safety of inhalers which combine corticosteroids with long acting bronchodilators (Advair, Breo, Dulera, and Symbicort) in controlling asthma symptoms in those with persistent, moderate to severe asthma.

Our highly trained physicians, nurses and staff know that asthma symptoms can make day-to-day life difficult.

• Do you have trouble breathing or coughing?
• Difficulty making it through a work-out or playing sports?
• Chest tightness?
• Wheezing?
• Shortness of breath?
• Trouble breathing in the cold or seasonally?

Whether your symptoms are newly developed or have been around for years, The Asthma Center offers individualized treatment plans and comprehensive care for our patients.  Click here to learn more about asthma, and how we help individuals with asthma Get Relief!

Subscribe  to receive News from The Asthma Center, our Daily Pollen and Mold Spore Count, the Delaware Valley’s only Official count station which is certified by the National Allergy Bureau, Office Location & Shot Hour updates, and more.

Media inquiries:  gwoodlyn@asthmacenter.com 215-569-1111.